DigitalOcean Lags Peers After Earnings as Analysts Cut Targets

DigitalOcean fell 15% over the past week, nearly double the median decline of 8% across its closest peers, with the Q3 earnings print now behind it and a fresh round of analyst target cuts arriving in its wake.

Among the peer group, the spread is wide. CRWV dropped 10% on the week while AKAM fell 13%, close to DOCN's level. VNET fared worst, losing 21%. On the other side, BBAI gained nearly 8%, and European peer OVH finished the week roughly flat. DOCN is not an outlier in absolute terms, but the depth of its one-month decline sets it apart: the stock has lost 35% over the past month, dropping to $90.50, while most peers are absorbing something closer to a correction than a rout.

The lending market is not reading this as a squeeze setup. Short interest has edged up to 11.7% of the free float, around 10.7 million shares, roughly where it has sat all month. The week-on-week increase is just over 2%, consistent with a slow grind rather than a pile-on. Availability is generous at 576%, meaning there is roughly six times as much stock available to borrow as is currently borrowed, far from the tight conditions that would generate covering pressure. Cost to borrow has also eased, dropping 13% over the week to 0.39%. The ORTEX short score edged up to 54.4 from 52.4 ten days ago, a mid-range reading that reflects elevated but stable positioning. None of this points to a structurally crowded short book.

Options positioning has shifted sharply toward calls. The put/call ratio dropped to 0.84, more than two standard deviations below its 20-day average of 1.01, its lowest reading in almost a year against a 52-week low of 0.31. For much of October the ratio sat above 1.0, reflecting consistent demand for downside protection into the print. The reversal since the November 3 results suggests options traders are either unwinding hedges or adding call exposure after the selloff, a notable change in market lean even as the stock remains well below September levels.

The Street is adjusting targets down but not abandoning ratings. Barclays lowered its price target to $140 from $161 on November 4, maintaining Overweight. Morgan Stanley cut to $150 from $175 on the same day, also keeping Overweight. UBS trimmed to $105 from $125 in late October, holding Neutral. The consensus mean target sits at $168, nearly double the current price, a gap that reflects how far the stock has fallen rather than any recent upgrade cycle. The analyst recommendation differential ranks in the 99th percentile on ORTEX's factor scores, meaning the spread between buy ratings and sell ratings is exceptionally high relative to the broader universe. EPS momentum over 30 and 90 days also scores well, at the 94th and 82nd percentiles respectively, suggesting estimate revisions have been running positively into this print. The bear case centres on capital intensity: colocation costs, depreciation, and lease obligations are arriving before revenue utilization, keeping free cash flow margins compressed and amplifying downside if new capacity earns inadequate returns.

The ownership picture carries one structural feature worth noting. Access Industries holds 15.9% of shares under a Schedule 13D, flagging active investor intent. Its most recent amendment, filed in August, showed a reduction from 17.9%. As with all 13D/G disclosures, the stake is as-last-reported around the 5% threshold, and the position may have changed since. JP Morgan Asset Management reported a large increase to 8.7% of shares as of September 30, adding over 6.5 million shares in its most recent period. The two moves together, one large holder trimming and another institutional name building, describe an ownership register in flux beneath the surface price action.

Wikipedia attention for DOCN is running more than two standard deviations above its own 90-day history, the highest retail attention reading in the tracked window. That is a colour point rather than a revenue signal, but it does suggest the post-earnings selloff has drawn a wider audience to the name than usual.

The clearest level to watch is the gap between the current price and the analyst target distribution, particularly whether further target cuts bring the consensus mean closer to where the stock is actually trading, or whether the Q3 numbers stabilise the revision cycle before the next scheduled print in February.